Adverse drug reaction monitoring in a secondary care hospital in South India

被引:75
作者
Arulmani, R. [1 ]
Rajendran, S. D. [1 ]
Suresh, B. [1 ]
机构
[1] JSS Coll Pharm, Dept Pharm Practice, Ootacamund 643001, India
关键词
adverse drug reactions; cost; inpatients; pharmacist; severity; spontaneous reporting;
D O I
10.1111/j.1365-2125.2007.02993.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
AIMS To ascertain the current burden of ADRs at a Government hospital in Ooty and to assess the severity of reported ADRs and the additional financial burden associated with ADRs. METHODS A prospective, spontaneous reporting study was conducted over a period of 9 months of inpatient admissions to the medical wards, co-ordinated by clinical pharmacists. The WHO definition of an ADR was adopted. The Naranjo algorithm scale was used for causality assessment. Confirmed ADRs were classified according to the Wills & Brown [7] method and assessed for severity and patient outcomes. The average cost incurred in treating the ADRs was calculated. RESULTS Of the total of 187 adverse drug events (ADEs) reported, 164 reports from 121 patients were confirmed as ADRs, giving an overall incidence of 9.8%. This included 58 (3.4%) ADR related admissions and 63 (3.7%) ADRs occurring during the hospital stay. About two thirds of the reactions (102, 62.2%) were classified as probable. The majority of the reactions (88, 53.7%) were mild. Most patients (119, 72.6%) recovered from the incidence. The majority of the reactions were of type H (100, 61%) which indicates that they were not predictable and not potentially preventable. An average cost of 481 rupees (6) pound was spent on each patient to manage ADRs. CONCLUSIONS The incidence and severity of ADRs documented in our study are lower than those reported in comparable populations in Western studies but more than those reported in India.
引用
收藏
页码:210 / 216
页数:7
相关论文
共 24 条
[1]   Reporting of adverse drug reactions: predictors of under-reporting in Malaysia [J].
Aziz, Zoriah ;
Siang, Tan Ching ;
Badarudin, Nurul Suhaida .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (02) :223-228
[2]   The costs of adverse drug events in hospitalized patients [J].
Bates, DW ;
Spell, N ;
Cullen, DJ ;
Burdick, E ;
Laird, N ;
Petersen, LA ;
Small, SD ;
Sweitzer, BJ ;
Leape, LL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :307-311
[3]   Hospitalisations caused by adverse drug reactions (ADR): a meta-analysis of observational studies [J].
Beijer, HJM ;
de Blaey, CJ .
PHARMACY WORLD & SCIENCE, 2002, 24 (02) :46-54
[4]   Analysis of the direct cost of adverse drug reactions in hospitalised patients [J].
Bordet, R ;
Gautier, S ;
Le Louet, H ;
Dupuis, B ;
Caron, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 56 (12) :935-941
[5]   COMPUTERIZED SURVEILLANCE OF ADVERSE DRUG EVENTS IN HOSPITAL PATIENTS [J].
CLASSEN, DC ;
PESTOTNIK, SL ;
EVANS, RS ;
BURKE, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (20) :2847-2851
[6]   Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality [J].
Classen, DC ;
Pestotnik, SL ;
Evans, RS ;
Lloyd, JF ;
Burke, JP .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (04) :301-306
[7]  
Dhikav V., 2004, J Indian Acad Clin Med, V5, P27
[8]  
Gonzalez-Martin G, 1998, INT J CLIN PHARM TH, V36, P530
[9]  
GREEN CF, 1997, HOSP PHARM, V4, P75
[10]   PREVENTABILITY AND SEVERITY ASSESSMENT IN REPORTING ADVERSE DRUG-REACTIONS [J].
HARTWIG, SC ;
SIEGEL, J ;
SCHNEIDER, PJ .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1992, 49 (09) :2229-2232